Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study on the Efficacy and Safety of Repeated Treatments With Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines

Chongqing Claruvis Pharmaceutical Co., Ltd. · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
moderate to severe glabellar lines, yy001, recombinant botulinum toxin type a, botulinum toxin, glabellar lines, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 805633
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.